Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Ocular Therapeutix, Inc.(OCUL) | 1,014,940 | 1,165,206 | +150,266 | $9.42M | $13.62M | 14.08% | +$4.20M |
| Cidara Therapeutics Inc | 179,569 | 141,529 | -38,040 | $8.75M | $13.55M | 14.01% | +$4.81M |
| Tourmaline Bio Inc | 283,682 | 268,451 | -15,231 | $4.54M | $12.84M | 13.27% | +$8.30M |
| Whitehawk Therapeutics, Inc.(WHWK) | 3,410,402 | 3,410,402 | 0 | $6.38M | $6.48M | 6.70% | +$102.3K |
| Insmed Incorporated(INSM) | 37,070 | 38,592 | +1,522 | $3.73M | $5.56M | 5.74% | +$1.83M |
| Bright Minds Biosciences Inc.(DRUG) | 48,474 | 84,875 | +36,401 | $1.27M | $5.15M | 5.32% | +$3.88M |
| argenx SEADR(ARGX) | 6,702 | 6,379 | -323 | $3.69M | $4.70M | 4.86% | +$1.01M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 0 | 333,258 | +333,258 | $0 | $4.53M | 4.68% | +$4.53M |
| Terns Pharmaceuticals Inc | 463,864 | 502,797 | +38,933 | $1.73M | $3.78M | 3.90% | +$2.05M |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 26,283 | 25,114 | -1,169 | $2.79M | $3.31M | 3.42% | +$520.9K |
| Compass Therapeutics, Inc.(CMPX) | 0 | 840,090 | +840,090 | $0 | $2.94M | 3.04% | +$2.94M |
| Praxis Precision Medicines, Inc.(PRAX) | 74,087 | 49,751 | -24,336 | $3.12M | $2.64M | 2.72% | -$478.6K |
| Surrozen, Inc.(SRZN) | 170,000 | 178,415 | +8,415 | $1.52M | $2.30M | 2.38% | +$779.1K |
| Ascendis Pharma A/SADR(ASND) | 22,576 | 9,792 | -12,784 | $3.90M | $1.95M | 2.01% | -$1.95M |
| Krystal Biotech, Inc.(KRYS) | 0 | 10,573 | +10,573 | $0 | $1.87M | 1.93% | +$1.87M |
| Oculis Holding AG(OCS) | 106,718 | 101,777 | -4,941 | $2.07M | $1.79M | 1.85% | -$282.2K |
| Taysha Gene Therapies, Inc.(TSHA) | 485,669 | 454,827 | -30,842 | $1.12M | $1.49M | 1.54% | +$365.4K |
| Cogent Biosciences, Inc.(COGT) | 0 | 102,907 | +102,907 | $0 | $1.48M | 1.53% | +$1.48M |
| Zymeworks Inc.(ZYME) | 83,655 | 80,143 | -3,512 | $1.05M | $1.37M | 1.41% | +$319.0K |
| Verastem, Inc.(VSTM) | 150,414 | 143,446 | -6,968 | $624.2K | $1.27M | 1.31% | +$642.4K |
| Dianthus Therapeutics, Inc.(DNTH) | 0 | 25,000 | +25,000 | $0 | $983.8K | 1.02% | +$983.8K |
| United Therapeutics Corporation(UTHR) | 0 | 2,296 | +2,296 | $0 | $962.5K | 0.99% | +$962.5K |
| Inhibrx Biosciences, Inc.(INBX) | 0 | 16,377 | +16,377 | $0 | $551.6K | 0.57% | +$551.6K |
| Fulcrum Therapeutics, Inc.(FULC) | 59,650 | 57,141 | -2,509 | $410.4K | $525.7K | 0.54% | +$115.3K |
| LB Pharmaceuticals Inc(LBRX) | 0 | 30,000 | +30,000 | $0 | $473.7K | 0.49% | +$473.7K |
| Revolution Medicines, Inc.(RVMD) | 55,693 | 8,411 | -47,282 | $2.05M | $392.8K | 0.41% | -$1.66M |
| Unicycive Therapeutics, Inc.(UNCY) | 62,899 | 59,985 | -2,914 | $300.0K | $261.5K | 0.27% | -$38.5K |
| Nuvation Bio Inc.W EXP 07 07 2027(NUVB) | 90,832 | 90,832 | 0 | $24.5K | $18.4K | 0.02% | -$6.2K |
| Akero Therapeutics Inc | 19,772 | 0 | -19,772 | $1.06M | $0 | — | -$1.06M |
| Artiva Biotherapeutics, Inc.(ARTV) | 45,456 | 0 | -45,456 | $68.6K | $0 | — | -$68.6K |
| Helix Acquisition Corp IiCL A | 187,257 | 0 | -187,257 | $1.99M | $0 | — | -$1.99M |
| Liquidia Corporation(LQDA) | 75,876 | 0 | -75,876 | $945.4K | $0 | — | -$945.4K |
| Rapport Therapeutics, Inc.(RAPP) | 20,000 | 0 | -20,000 | $227.4K | $0 | — | -$227.4K |
| Soleno Therapeutics Inc | 63,436 | 0 | -63,436 | $5.31M | $0 | — | -$5.31M |
| Trevi Therapeutics, Inc.(TRVI) | 493,735 | 0 | -493,735 | $2.70M | $0 | — | -$2.70M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 23,814 | 0 | -23,814 | $865.9K | $0 | — | -$865.9K |